PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Clinical evidence
Leaf extracts demonstrated antibacterial and antifungal efficacy against these microorganisms [PMID:40901441]
Silver nanoparticles synthesized using C. fruticosa leaf extract as a reducing and capping agent exhibited effective antibacterial activities [PMID:35745988]
Steroidal saponins fruticoside K and M exhibited weak cytotoxicity [PMID:30910736]
Evidence summary
PubMed sources
- 1.PMID: 23881274 (2013) — Differentiation and distribution of cordyline viruses 1-4 in Hawaiian ti plants (Cordyline fruticosa L.). · Viruses
- 2.PMID: 34624728 (2021) — Steroidal glycosides from the Vietnamese cultivar Cordyline fruticosa "Fairchild red". · Phytochemistry
- 3.PMID: 35745988 (2022) — Fabrication of Silver Nanoparticles Using Cordyline fruticosa L. Leave Extract Endowing Silk Fibroin Modified Viscose Fabric with Durable Antibacterial Property. · Polymers
- 4.PMID: 40901441 (2025) — Identification of bioactive compounds in Cordyline fruticosa (L.) A. Chev. leaf extract and its antimicrobial activity against cariogenic microorganisms. · Journal of advanced pharmaceutical technology & research
- 5.PMID: 21636452